In the article by Chalmers et al (Chalmers J, Arima H, Woodward M, Mancia G, Poulter N, Hirakawa Y, Zoungas S, Patel A, Williams B, Harrap S. Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial. Hypertension. 2014;63:259–264. doi: 10.1161/HYPERTENSIONAHA.113.02252), which published online ahead of print December 9, 2013, and appeared in the February 2014 issue of the journal, a correction was needed.
Dr Mancia’s affiliation read “University of Milan-Bicocca, Milan, Italy.” This has been changed to read “IRCCS Istituto Auxologico Italiano and University of Milan-Bicocca, Milan, Italy.”
The authors apologize for this error.
These corrections have been made to the current online version of the article, which is available at http://hyper.ahajournals.org/content/63/2/259.full.
- © 2015 American Heart Association, Inc.